SteinCares and Shilpa Biologicals Strike into licensing agreement to Expand Access to Biosimilars Across Latin America

by victoria.carrillo | Feb 24, 2026 | Press Releases

New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform Collaboration aims to expand patient access to cost-effective treatments and reinforces SteinCares’ leadership in biosimilars...

Bio-Thera Solutions and SteinCares Expand Partnership to Commercialize Biosimilars for Treatment of Inflammatory Diseases Across Latin America

by victoria.carrillo | Jun 24, 2025 | Press Releases

This new agreement marks the fourth product in the partnership and introduces a potential cost-effective alternative to one of the world’s top-selling biologics—broadening access to specialty care for patients with chronic inflammatory diseases. The partnership...

Bio-Thera Solutions and SteinCares Expand Partnership with Addition of a Third Biosimilar in LATAM 

by victoria.carrillo | Dec 19, 2024 | Press Releases

GUANGZHOU, China and San Jose, Costa Rica – SteinCares, a leading specialty healthcare company in Latin America, and Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced an expansion...

Bio-Thera Solutions Partners with SteinCares to Market Two Biosimilars in LATAM

by victoria.carrillo | Mar 18, 2024 | Press Releases

Guangzhou, China and San José, Costa Rica – Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, and SteinCares, one of Latin America’s leading specialty healthcare companies, announced today a new...